188 related articles for article (PubMed ID: 28203638)
1. Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy.
Arnold KM; Flynn NJ; Sims-Mourtada J
Cancer Stud Mol Med; 2015; 2(2):80-86. PubMed ID: 28203638
[TBL] [Abstract][Full Text] [Related]
2. Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy.
Sims-Mourtada J; Opdenaker LM; Davis J; Arnold KM; Flynn D
Mol Carcinog; 2015 Nov; 54(11):1480-93. PubMed ID: 25263583
[TBL] [Abstract][Full Text] [Related]
3. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
4. The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Bhateja P; Cherian M; Majumder S; Ramaswamy B
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394751
[TBL] [Abstract][Full Text] [Related]
5. Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.
Li M; Guo T; Lin J; Huang X; Ke Q; Wu Y; Fang C; Hu C
J Ethnopharmacol; 2022 Jan; 283():114689. PubMed ID: 34592340
[TBL] [Abstract][Full Text] [Related]
6. Targeting triple negative breast cancer stem cells using nanocarriers.
Dasari N; Guntuku GS; Pindiprolu SKSS
Discov Nano; 2024 Mar; 19(1):41. PubMed ID: 38453756
[TBL] [Abstract][Full Text] [Related]
7. Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer.
Arnold KM; Pohlig RT; Sims-Mourtada J
Oncol Lett; 2017 Nov; 14(5):5285-5292. PubMed ID: 29142600
[TBL] [Abstract][Full Text] [Related]
8. Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling.
Bernemann C; Hülsewig C; Ruckert C; Schäfer S; Blümel L; Hempel G; Götte M; Greve B; Barth PJ; Kiesel L; Liedtke C
Mol Cancer; 2014 Jul; 13():174. PubMed ID: 25033833
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Sonic Hedgehog Signaling Pathway by Thiazole Antibiotic Thiostrepton Attenuates the CD44+/CD24-Stem-Like Population and Sphere-Forming Capacity in Triple-Negative Breast Cancer.
Yang N; Zhou TC; Lei XX; Wang C; Yan M; Wang ZF; Liu W; Wang J; Ming KH; Wang BC; Xu BL; Liu Q
Cell Physiol Biochem; 2016; 38(3):1157-70. PubMed ID: 26963129
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
Sims-Mourtada J; Izzo JG; Apisarnthanarax S; Wu TT; Malhotra U; Luthra R; Liao Z; Komaki R; van der Kogel A; Ajani J; Chao KS
Clin Cancer Res; 2006 Nov; 12(21):6565-72. PubMed ID: 17085672
[TBL] [Abstract][Full Text] [Related]
11. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
[TBL] [Abstract][Full Text] [Related]
12. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment.
Chang HR; Glaspy J; Allison MA; Kass FC; Elashoff R; Chung DU; Gornbein J
Cancer; 2010 Sep; 116(18):4227-37. PubMed ID: 20549829
[TBL] [Abstract][Full Text] [Related]
13. The hedgehog pathway in triple-negative breast cancer.
Habib JG; O'Shaughnessy JA
Cancer Med; 2016 Oct; 5(10):2989-3006. PubMed ID: 27539549
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
15. Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
Li S; Payne S; Wang F; Claus P; Su Z; Groth J; Geradts J; de Ridder G; Alvarez R; Marcom PK; Pizzo SV; Bachelder RE
Breast Cancer Res; 2015 Jul; 17(1):91. PubMed ID: 26141457
[TBL] [Abstract][Full Text] [Related]
16. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
[TBL] [Abstract][Full Text] [Related]
19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
20. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
